162 related articles for article (PubMed ID: 38397931)
1. Tumor-Derived Sarcopenia Factors Are Diverse in Different Tumor Types: A Pan-Cancer Analysis.
Gan X; Zeng Y; Huang J; Chen X; Kang H; Huang S
Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397931
[TBL] [Abstract][Full Text] [Related]
2. The expression landscape of cachexia-inducing factors in human cancers.
Freire PP; Fernandez GJ; de Moraes D; Cury SS; Dal Pai-Silva M; Dos Reis PP; Rogatto SR; Carvalho RF
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):947-961. PubMed ID: 32125790
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients.
Ubachs J; van de Worp WRPH; Vaes RDW; Pasmans K; Langen RC; Meex RCR; van Bijnen AAJHM; Lambrechts S; Van Gorp T; Kruitwagen RFPM; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):311-324. PubMed ID: 34951138
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Associated Muscle Wasting-Candidate Mechanisms and Molecular Pathways.
Armstrong VS; Fitzgerald LW; Bathe OF
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291708
[TBL] [Abstract][Full Text] [Related]
5. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer.
Daly LE; Ní Bhuachalla ÉB; Power DG; Cushen SJ; James K; Ryan AM
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):315-325. PubMed ID: 29318756
[TBL] [Abstract][Full Text] [Related]
6. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of spliceosome genes and their mutants across 27 cancer types in 9070 patients: clinically relevant outcomes in the context of 3P medicine.
Ye Z; Bing A; Zhao S; Yi S; Zhan X
EPMA J; 2022 Jun; 13(2):335-350. PubMed ID: 35719132
[TBL] [Abstract][Full Text] [Related]
8. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
9. Exosomal microRNAs in cancer-related sarcopenia: Tumor-derived exosomal microRNAs in muscle atrophy.
Li C; Wu Q; Li Z; Wang Z; Tu Y; Chen C; Sun S; Sun S
Exp Biol Med (Maywood); 2021 May; 246(10):1156-1166. PubMed ID: 33554647
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
Lin Y; Dong Y; Liu W; Fan X; Sun Y
Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
[TBL] [Abstract][Full Text] [Related]
11. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
[TBL] [Abstract][Full Text] [Related]
12. A pan-cancer analysis of RNASEH1, a potential regulator of the tumor microenvironment.
Yi C; Yang J; Zhang T; Xie S; Li W; Qin L; Chen D
Clin Transl Oncol; 2023 Aug; 25(8):2569-2586. PubMed ID: 37022517
[TBL] [Abstract][Full Text] [Related]
13. Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation.
Naumann P; Eberlein J; Farnia B; Hackert T; Debus J; Combs SE
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31126040
[No Abstract] [Full Text] [Related]
14. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
Şahin MEH; Akbaş F; Yardimci AH; Şahin E
BMC Cancer; 2023 Sep; 23(1):911. PubMed ID: 37770828
[TBL] [Abstract][Full Text] [Related]
15. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
Li Y; Kang K; Krahn JM; Croutwater N; Lee K; Umbach DM; Li L
BMC Genomics; 2017 Jul; 18(1):508. PubMed ID: 28673244
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
Baracos VE; Arribas L
Ann Oncol; 2018 Feb; 29(suppl_2):ii1-ii9. PubMed ID: 29506228
[TBL] [Abstract][Full Text] [Related]
18. FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.
Zhong A; Chen T; Xing Y; Pan X; Shi M
Front Immunol; 2021; 12():758648. PubMed ID: 34745134
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults.
Tan L; Ji G; Bao T; Fu H; Yang L; Yang M
Insights Imaging; 2021 Nov; 12(1):163. PubMed ID: 34743259
[TBL] [Abstract][Full Text] [Related]
20. Defining Normal Ranges of Skeletal Muscle Area and Skeletal Muscle Index in Children on CT Using an Automated Deep Learning Pipeline: Implications for Sarcopenia Diagnosis.
Somasundaram E; Castiglione JA; Brady SL; Trout AT
AJR Am J Roentgenol; 2022 Aug; 219(2):326-336. PubMed ID: 35234481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
